and in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the ... the sustained delivery of medicines for retinal and vitreous diseases, according to a new report by ... Dr. Murphree is also Professor of Ophthalmology and Pediatrics at the Keck School of Medicine of the ...

Regular Yoga Practice Is Associated With Mindful Eating

... yoga practice is associated with mindful eating, and people who eat mindfully are less likely to be ... reported four years ago by Alan Kristal, Dr.P.H., and colleagues, who found that regular yoga practice ... prevent middle-age spread in normal-weight people and may promote weight loss in those who are ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... LYON, France and SWIFTWATER, Pa., Aug. 7 /PRNewswire/ -- Sanofi ... of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), announced today the company has submitted to the U.S. Food and Drug Administration (FDA) a supplemental ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... M.D., Ph.D., executive vice president of Research and Development at Amgen. "These are the first ... events such as skin toxicity, hypomagnesemia and diarrhea. Originally designed to compare ... findings when oxaliplatin-based chemotherapy and an anti-EGFR antibody are combined. "Our ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... to successfully execute its business strategy and as a result reported $669,000 of pro forma net ... ended the quarter with $637.5 million of cash and remains on track to end 2009 with more than $550 ... of more than $145 million of pro forma net income and a pro forma net operating loss in the low to mid ...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year ... the agenda for diabetes research worldwide and the largest charitable ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... treatment to a patient's cancerous tumor and is rapidly becoming the treatment of choice for ... precise delivery, the surrounding healthy tissue and critical organs are preferentially spared from high doses of radiation and side effects may be reduced. Unlike low ...

SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite

... Oracle Siebel Clinical Trial Management System and Oracle Adverse Events Reporting System. ... us manage critical tasks in clinical operations and drug safety in an efficient and globally compliant manner, thus providing our ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... bone mineral density (BMD) at the lumbar spine and femoral neck (a common fracture site located in ... six months of therapy. The gains in lumbar spine and femoral neck BMD were further increased in a ... therapy for a total of 12 months of treatment, and at both time points, the changes were greater ...

NewCardio Announces Master Services Agreement With Dedicated Phase I

... (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dedicated ... including a Core ECG laboratory for Thorough QT and QTc studies, has signed a Master Services ... its customers. Jason Bonanza, President and CEO of Dedicated Phase I, commented, "We are ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... Canada," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We ... opportunity for our trazodone formulation and we are currently in discussions with potential ... on data from five pivotal pharmacokinetic studies and the positive results from a North American Phase ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... VLP vaccine to support human clinical studies and stands ready to assist with additional public ... Mr. Jim Robinson, Vice President of Manufacturing and Quality Operations at Novavax, commented, "Demonstration of our ability to construct and produce GMP-quality influenza vaccine within 12 ...

2,500 Cases Completed With the Magnetic Irrigated Catheter

... of medicine at The Ohio State University and an electrophysiologist at the Ross Heart Hospital ... arrhythmias in all four chambers of the heart and across a broad spectrum of patients ranging from ... in patients with congenital heart defects and patients with peripheral vascular occlusive ...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... as compared to a year ago. Total operating costs and expenses were down 19% to $43.5 million in the ... For the first half of 2009, total operating costs and expenses were down 28% to $83.5 million as ... pipeline," stated Howard W. Robin, President and Chief Executive Officer of Nektar. "We completed ...

DNA Helps Reunite Children With Their Families

... Arthur Eisenberg, Ph.D., professor and chairman of the department of forensic and investigative Genetics and co-director of the UNT Center for Human ...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

... -- ARUP Laboratories , a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, supports the U.S. ...

Study Shows Brain Fitness can Save Medicare Billions

... brain fitness exercises can have a significant and long lasting impact on healthcare costs and outcomes, according to a study recently published ... trial funded by the National Institutes of Health and known as the Advanced Cognitive Training for ...

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research

... team to make a real difference to the diagnosis and treatment of a disease that counts among the ... In total, more than 100 partners from industry and academia are involved in the projects, which are ... the basis of 25% from industry, 25% from academia and 50% from the Dutch government. About CTMM ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... LAUSANNE, Switzerland and WOBURN, Massachusetts, August 4 /PRNewswire/ ... drugs that target unmet medical needs, and Mercury Therapeutics, Inc. (Mercury), a privately ... exclusive license agreement for the development and commercialisation of Debio 0930, a small molecule ...

Scientists Discover Origin of Malaria

... Ph.D., of the Global Viral Forecasting Initiative and Stanford University, made the discovery, ... animals to humans, much the way that HIV, SARS and swine flu originated. "This discovery ... parasites had co-existed separately in human and chimpanzee ancestors for the last 5 million ....

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. ... Overall, the incidence of adverse events and serious adverse events was consistent with what ... of osteonecrosis of the jaw (ONJ) were balanced and infrequent in both treatment groups (10 patients ...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

... published earlier in the Journal of Hematology and Oncology, 13 May 2009; Vol. 2, No.20, pp. 20-32. ... MDS (enrollment completion expected by year end), and Severe Chronic Idiopathic Neutropenia. Reprints ... available from Telik. Background on MDS and TELINTRA MDS is a heterogeneous group of ...

Project Zero Delay Accelerates Drug's Path to Clinical Trial

... HOUSTON and WILMINGTON, Del., Aug. 3 /PRNewswire-FirstCall/ ... its first patient only two days after U.S. Food and Drug Administration clearance of the experimental ... University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported ...

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

... two new publications on hormone therapies and their effects on reducing the risks of ... that commonly support the heart, brain, kidneys and extremities, and cause blood clots, heart ...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

... papers on a variety of cervical cancer issues and topics that were the focus of its Forum " The ... may have on rates of cervical precancer and cervical cancer screening, strategies to measure vaccine uptake and obstacles surrounding separate screening for ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... N.J., Aug. 3 /PRNewswire/ -- The U.S. Food and Drug Administration approved INVEGA(R) ... injectable suspension for the acute and maintenance treatment of schizophrenia in adults ... ability to think clearly, relate to others, and distinguish between ...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

... in France. The study will examine dose levels and regimens of ProLindac monotherapy in cancer ... data to support design of combinations studies, and extend the safety database. Two ovarian cancer patients have been enrolled in the study to date, and it is anticipated 6 to 12 patients will be ...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

... OMER and MIGDAL HA'EMEK, Israel, August 3 ... (TASE: MDGS) a leading developer of endoscopic and visualization medical devices, and Tower Semiconductor, Ltd. (Nasdaq: TSEM , TASE: ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

... The Company also announced that the U.S. Food and Drug Administration (FDA) has accepted its treatment protocol for velaglucerase alfa and that Shire has begun its rolling submission of ... velaglucerase alfa program from both a clinical and regulatory perspective," said Sylvie ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced results from a study ... the combination of OPAXIO (paclitaxel poliglumex) and Alimta(R) (pemetrexed) was well tolerated and resulted in median progression-free survival of ....

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

... 29 /PRNewswire/ -- Grammy-Award winning artist and long-time (PRODUCT)RED supporter John Legend is ... they provide an innovative way for great brands and great artists to come together to powerfully and effectively fight AIDS in Africa," said Legend. ...

Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus

... prevention, monitor the spread of infection, and track vaccination compliance. FairChoice Health is the first and only end-to-end service for vaccination compliance management specifically designed for colleges and universities. The enhancement of ...

GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip

... Clinton's decision to visit Africa next week and her decision to focus attention during her visit on preventing conflict and violence, including gender-based violence, on the African continent. Violence against women (VAW) and violence against children (VAC) are issues in ...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

... at two US centers, as a blinded, randomized, and placebo-controlled study, in 30 patients ... objective was to assess the safety, tolerability, and pharmacokinetics of PSI-7851 after once-daily ... of -0.49 log(10) IU/mL, -0.61 log(10) IU/mL and -1.01 log(10) IU/mL in patients receiving 50mg ...

British Woman Celebrates a Year of Living Cancer-Free

... a cancer treatment that changed her life -- and made history to boot. Ms. Scott, 54, was the ... of traditional treatments, including chemotherapy and a bone marrow transplant, failed to keep her in ... felt fine immediately. I was going out to dinner and things like that," Ms. Scott said. "It was really ...

Covance Receives Highest Level of Phase I Accreditation

... today announced that it has received standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA). ... process provides clinical trial volunteers and sponsors with confidence that research ...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... FL, the data suggests that this treatment is safe and potentially leads to improved outcomes for a ... Raul Nogueira, M.D., Assistant in Neurology and Radiology at Massachusetts General Hospital -- ... the 237 study participants, 49 percent were males and 51 percent were females, with a mean (or average) ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic ... (asenapine) sublingual tablets as effective and safe for the acute treatment of manic or mixed ... associated with bipolar I disorder in adults and in favor of use in acute treatment of ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

... biologic pathway using an integrated and innovative array of in vitro readouts and advanced in vivo imaging technologies. The ... are expected to open up new areas of research and potentially advance therapeutic approaches to key ...

New Powder Speeds Healing of Difficult Foot Wounds

... -- Foot complications, such as open wounds and ulcers, can be one of the most difficult ailments ... of skin, is proving to speed the healing time and reduce the amount of pain that a patient ... Meeting in Toronto, July 30 - August 2, 2009, and will highlight the powder's unique ability to ...